title: CD68 and CD163 as prognostic factors for Korean patients with Hodgkin lymphoma.
abstract: BACKGROUND
  Limited progress had been made in prognostic stratification of patients with Hodgkin lymphoma (HL) until recent studies suggested that the number of CD68-expressing macrophages is prognostic in classical HL. However, its significance in Asian patients with HL has not been explored yet perhaps because of its low incidence in Asia.
  
  
  METHODS
  In this work, we performed immunohistochemical analysis of CD163, as well as CD68, in 144 Korean patients with HL treated between November 1990 and December 2009 in a single center. The relative percentages of CD68+ and CD163+ cells with respect to the overall cellularity (CD68 index and CD163 index, respectively) were correlated with clinical outcomes.
  
  
  RESULTS
  Both high CD68 and CD163 indices (>20%) were associated with a rise in treatment-related deaths and poorer event-free survival (P = 0.009 and P = 0.0023, respectively), disease-specific survival (P = 0.011 and P = 0.001), and overall survival (P = 0.023 and P = 0.001). In particular, a high CD163 index was related to lower complete response (CR) rate (P = 0.022) and shorter duration of CR (P = 0.030).
  
  
  CONCLUSIONS
  High index of either CD68 or CD163 (>20%) is significantly correlated with poor prognosis in Korean patients with HL. CD163, a specific marker of macrophages, seems to be another prognostic factor for classical HL.
authors: Departments of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
authors: Dok Hyun
authors: DH
authors: Yoon
authors: Young Wha
authors: YW
authors: Koh
authors: Hyo Jeong
authors: HJ
authors: Kang
authors: Shin
authors: S
authors: Kim
authors: Chan-Sik
authors: CS
authors: Park
authors: Sang-Wook
authors: SW
authors: Lee
authors: Cheolwon
authors: C
authors: Suh
authors: Jooryung
authors: J
authors: Huh
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D015703:Antigens, CD / Q000096:biosynthesis*; D015214:Antigens, Differentiation, Myelomonocytic / Q000096:biosynthesis*; D018572:Disease-Free Survival; D005260:Female; D006689:Hodgkin Disease / Q000175:diagnosis* / Q000208:ethnology* / Q000235:genetics*; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D007723:Korea; D008264:Macrophages / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011956:Receptors, Cell Surface / Q000096:biosynthesis*; D000098902:CD163 Antigen; D000097382:CD68 Molecule
chemical_list: D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D011956:Receptors, Cell Surface; D000098902:CD163 Antigen; C067980:CD68 antigen, human; D000097382:CD68 Molecule